Diflunisal News
Diflunisal currently has 2 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Diflunisal with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Attrogy is indicated for the treatment of hereditary transthyretin-mediated amyloidosis (ATTRv) in adult patients with stage 1 or stage 2 polyneuropathy.
- Evidence level: L1
- Predicted indications (20):
- osteoarthritis susceptibility (100.0%)
- acromesomelic dysplasia, Hunter-Thompson type (100.0%)
- brachyolmia-amelogenesis imperfecta syndrome (100.0%)
- spondyloarthropathy, susceptibility to (100.0%)
- rheumatoid arthritis (100.0%)
- myosclerosis (100.0%)
- osteoarthritis (100.0%)
- ankylosing spondylitis (100.0%)
- brachyolmia (100.0%)
- arthropathy (100.0%)
- hypermobility of coccyx (100.0%)
- rheumatoid vasculitis (100.0%)
- colobomatous microphthalmia-rhizomelic dysplasia syndrome (100.0%)
- inflammatory spondylopathy (100.0%)
- brachydactyly-syndactyly syndrome (100.0%)
- polyarticular juvenile rheumatoid arthritis (100.0%)
- Kummell disease (100.0%)
- pseudoachondroplasia (100.0%)
- vertebral disease (99.9%)
- WHIM syndrome (99.9%)
Related News (2)
A surprisingly simple way to relieve knee arthritis pain without pills or surgery - Science Daily
2026-10-11 arthritis
Source: Science Daily
Knee pain and crunching: 3 exercises to ease osteoarthritis of the kneecap - South China Morning Post
2026-10-09 arthritis
Source: South China Morning Post
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.